The interest for adjunctive therapy, such as the use of erythropoietin in children suffering of cerebral malaria is now increasing [51], and it is conceivable that activation of parasite metacaspases and/or of the downstream VAD-binding enzyme may help increase the speed of parasite clearance as well as the efficiency of anti-parasitic drugs. This evidence concerns the gene EPO and cerebral malaria.